Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate whether simtuzumab (formerly referred to as GS-6624) can reduce portal venous pressure and incidence of clinical events in subjects with cirrhosis due to NASH.
Inclusion criteria
- Compensated Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)